BHRF1, an early gene product of Epstein–Barr virus (EBV), is structurally and functionally homologous to Bcl-2, a cellular anti-apoptotic protein. BHRF1 has been shown to protect cells from apoptosis induced by numerous external stimuli. Nasopharyngeal carcinoma is an epithelial cancer associated closely with EBV infection. Specific proteins that might interact with and modulate the BHRF1 anti-apoptotic activity in normal epithelial cells are of interest. Therefore, a cDNA library derived from normal human foreskin keratinocytes was screened by the yeast two-hybrid system and a cellular gene encoding human vaccinia virus B1R kinase-related kinase 2 (VRK2) was isolated. Interaction between the cellular VRK2 and viral BHRF1 proteins was further demonstrated by glutathione S-transferase pull-down assays, confocal laser-scanning microscopy and co-immunoprecipitation. Analyses of VRK2-deletion mutants revealed that a 108 aa fragment at the C terminus was important for VRK2 to interact with BHRF1. For BHRF1, aa 1–18 and 89–142 were crucial in interacting with VRK2 and these two regions are counterparts of Bcl-2 homology domains 4 and 1. Overexpressed VRK2 alone showed a modest effect in anti-apoptosis and appeared to enhance cell survival in the presence of BHRF1. However, this enhancement was not observed when VRK2 was co-expressed with Bcl-2. The results indicate that human VRK2 interacts specifically with EBV BHRF1 and that the interaction is involved in protecting cells from apoptosis.
BonnetM.,
GuinebretiereJ.-M.,
KremmerE.,
GrunewaldV.,
BenhamouE.,
ContessoG.,
JoabI.1999; Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91:1376–1381[CrossRef]
BrinkA. A.,
van den BruleA. J.,
van DiestP.,
MeijerC. J.2000; Re: detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 92:655–656[CrossRef]
ChenM. R.,
HuangH.,
FenC. Y.,
ChenJ. Y.2000; A novel EBNA-1 tag system for high level expression and efficient detection of fusion proteins in vitro and in vivo. J Virol Methods 85:35–41[CrossRef]
ChiangA. K.,
TaoQ.,
SrivastavaG.,
HoF. C.1996; Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68:285–290[CrossRef]
ChouS.-P.,
TsaiC.-H.,
LiL.-Y.,
LiuM.-Y.,
ChenJ.-Y.2004; Characterization of monoclonal antibody to the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2. Hybrid Hybridomics 23:29–37[CrossRef]
ConditR. C.,
MotyczkaA.1981; Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology 113:224–241[CrossRef]
D'AgostinoD. M.,
BernardiP.,
Chieco-BianchiL.,
CiminaleV.2005; Mitochondria as functional targets of proteins coded by human tumor viruses. Adv Cancer Res 94:87–142
DawsonC. W.,
DawsonJ.,
JonesR.,
WardK.,
YoungL. S.1998; Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells. J Virol 72:9016–9024
GrahamF. L.,
SmileyJ.,
RussellW. C.,
NairnR.1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–72[CrossRef]
HellerM.,
DambaughT.,
KieffE.1981; Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. J Virol 38:632–648
HendersonS.,
HuenD.,
RoweM.,
DawsonC.,
JohnsonG.,
RickinsonA.1993; Epstein–Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90:8479–8483[CrossRef]
HickishT.,
RobertsonD.,
ClarkeP.,
HillM.,
di StefanoF.,
ClarkeC.,
CunninghamD.1994; Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res 54:2808–2811
HuangQ.,
PetrosA. M.,
VirginH. W.,
FesikS. W.,
OlejniczakE. T.2003; Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol 332:1123–1130[CrossRef]
KawanishiM.,
Tada-OikawaS.,
KawanishiS.2002; Epstein–Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem Biophys Res Commun 297:682–687[CrossRef]
KhanimF.,
DawsonC.,
MesedaC. A.,
DawsonJ.,
MackettM.,
YoungL. S.1997; BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein–Barr virus isolates. J Gen Virol 78:2987–2999
KovacsG. R.,
VasilakisN.,
MossB.2001; Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase. J Virol 75:4048–4055[CrossRef]
LeeJ.-H.,
TakahashiT.,
YasuharaN.,
InazawaJ.,
KamadaS.,
TsujimotoY.1999; Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18:6183–6190[CrossRef]
LiL.-Y.,
ShihH.-M.,
LiuM.-Y.,
ChenJ.-Y.2001; The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem 276:27354–27362[CrossRef]
LiuM.-Y.,
ShihY.-Y.,
LiL.-Y.,
ChouS.-P.,
SheenT.-S.,
ChenC.-L.,
YangC.-S.,
ChenJ.-Y.2000; Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue. J Med Virol 61:241–250[CrossRef]
LuB.,
BishopC. E.2003; Late onset of spermatogenesis and gain of fertility in POG-deficient mice indicate that POG is not necessary for the proliferation of spermatogonia. Biol Reprod 69:161–168[CrossRef]
MarchiniA.,
TomkinsonB.,
CohenJ. I.,
KieffE.1991; BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J Virol 65:5991–6000
MatsudaG.,
NakajimaK.,
KawaguchiY.,
YamanashiY.,
HiraiK.2003; Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol Immunol 47:91–99[CrossRef]
NezuJ.,
OkuA.,
JonesM. H.,
ShimaneM.1997; Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45:327–331[CrossRef]
NicholsR. J.,
TraktmanP.2004; Characterization of three paralogous members of the mammalian vaccinia related kinase family. J Biol Chem 279:7934–7946[CrossRef]
NicholsR. J.,
WiebeM. S.,
TraktmanP.2006; The vaccinia-related kinases phosphorylate the N′ terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell 17:2451–2464[CrossRef]
OdaK.,
TamaruJ.,
TakenouchiT.,
MikataA.,
NunomuraM.,
SaitohN.,
SarashinaH.,
NakajimaN.1993; Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 143:1063–1071
OudejansJ. J.,
van den BruleA. J. C.,
JiwaN. M.,
de BruinP. C.,
OssenkoppeleG. J.,
van der ValkP.,
WalboomersJ. M. M.,
MeijerC. J. L. M.1995; BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 86:1893–1902
PearsonG. R.,
LukaJ.,
PettiL.,
SampleJ.,
BirkenbachM.,
BraunD.,
KieffE.1987; Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151–161[CrossRef]
RempelR. E.,
AndersonM. K.,
EvansE.,
TraktmanP.1990; Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication. J Virol 64:574–583
RickinsonA. B.,
KieffE.2001; Epstein-Barr virus. In Fields Virology , 4th edn. pp 2575–2627 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott Williams & Wilkins;
SatoT.,
HanadaM.,
BodrugS.& 8 other authors1994; Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci U S A 91:9238–9242[CrossRef]
ShapiroR. S.,
McClainK.,
FrizzeraG.& 7 other authors1988; Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234–1243
TarodiB.,
SubramanianT.,
ChinnaduraiG.1994; Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201:404–407[CrossRef]
TheodorakisP.,
D'Sa-EipperC.,
SubramanianT.,
ChinnaduraiG.1996; Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene 12:1707–1713
TraktmanP.,
AndersonM. K.,
RempelR. E.1989; Vaccinia virus encodes an essential gene with strong homology to protein kinases. J Biol Chem 264:21458–21461
VegaF. M.,
GonzaloP.,
GasparM. L.,
LazoP. A.2003; Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett 544:176–180[CrossRef]
YinX.-M.,
OltvaiZ. N.,
KorsmeyerS. J.1994; BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321–323[CrossRef]
ZhangH.,
XuQ.,
KrajewskiS.& 7 other authors2000; BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci U S A 97:2597–2602[CrossRef]